Consider contacting Mark J. Leeds, a Pradaxa lawsuits lawyer if you have experienced adverse Pradaxa anticoagulant side effects.
Dabigatran is the active ingredient in the Pradaxa anticoagulant medication for nonvalvular atrial fibrillation (AF) patients – or patients who are being treated for abnormal heart rhythm. Atrial fibrillation patients take Pradaxa to thin their blood, which is the same reason why atrial fibrillation patients take another blood thinning medication, Warfarin. Whether abnormal heart rhythm patients are taking Warfarin blood thinner medication or are taking Pradaxa blood thinner medication, both of these anticoagulants are meant to help reduce a risk of blood clots and strokes.
Warfarin anticoagulant vs Pradaxa anticoagulant
There are similar risks associated with taking either Warfarin or Pradaxa blood thinning medication. Warfarin is the older, more established and better-known anticoagulant drug. Within weeks of the quick launch of the Pradaxa anticoagulant drug, hundreds of patients or their families reported adverse side effects, like internal bleeding, gastrointestinal bleeding, brain bleeding, and death.
Internal bleeding symptoms and signs may include:
Unusual colour urine
Red or dark stools
Coughing up blood
Weakness or lethargy
Brain blood clots in nonvalvular atrial fibrillation patients may occur when the blood of the patients has not been adequately thinned (atrial fibrillation anticoagulation.) On the other hand, if anticoagulation medicines “do their job too well” excessive bleeding may occur, and possibly result in internal bleeding, gastrointestinal bleeding, brain bleeding, and death.
Nonvalvular atrial fibrillation definition:
Nonvalvular atrial fibrillation (or nonvalvular AF) is when the patient with atrial fibrillation (abnormal heart rhythm) experiences any form of atrial fibrillation not related to if there is history or evidence of rheumatic mitral valve disease or if they have a prosthetic valve. The term for atrial fibrillation disease when there is evidence or history of rheumatic mitral valve disease or the patient has a prosthetic valve is valvular AF.
What does the FDA advise if you are taking Pradaxa (dabigatran etexilate mesylate) or suspect that you have internal bleeding:
FDA Drug Safety Communication: Safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate mesylate)
The FDA advises not to stop taking Pradaxa without speaking to your healthcare professional, as stopping taking Pradaxa may increase your risk of having a stroke. Speak to your physician or healthcare professional.
If wanting to know if you may be entitled to money compensation for your Pradaxa side effects, you may consider contacting a Pradaxa lawsuits lawyer.
Further Reading and Resources:
(18 November 2011)
European Medicines Agency updates on safety of Pradaxa
We are in no way connected with, nor do we have any affiliations to, the manufacturers or suppliers of Pradaxa or any other anticoagulant medications with the active ingredient Dabigatran.
Consult a Doctor
We do not intend, by this article or otherwise, to discourage anyone from taking Pradaxa. Please consult your doctor, not your lawyer, on matters relating to your health. Pradaxa patients should talk to their physicians, health care providers or surgeons to decide whether the benefits and risks of taking Pradaxa or any other anticoagulant medication containing Dabigatran is the right choice for them.
General information only
The contents of this website should not be relied upon as legal, health or medical advice, all information on this website is for general information only, and is not a substitute for a lawyer’s advice or a health professional’s advice.
For professional legal advice about Pradaxa, call Mark J. Leeds, on 954 683 0355, or Toll Free on 888-446-1999.
You can also contact Mr Leeds here